Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy

Bortezomib, a first-generation proteasome inhibitor widely used in chemotherapy for hematologic malignancy, has effective anti-cancer activity but often causes severe peripheral neuropathy. Although bortezomib-induced peripheral neuropathy (BIPN) is a dose-limiting toxicity, there are no recommended...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Shota, Egashira, Nobuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830235/
https://www.ncbi.nlm.nih.gov/pubmed/33477371
http://dx.doi.org/10.3390/ijms22020888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830235/
https://www.ncbi.nlm.nih.gov/pubmed/33477371
http://dx.doi.org/10.3390/ijms22020888

Ejemplares similares